BMSSC
TNDM icon

B. Metzler seel. Sohn & Co’s Tandem Diabetes Care TNDM Stock Holding History

B. Metzler seel. Sohn & Co’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-21,870
Closed -$788K – 764
2024
Q4 		$788K Buy
+21,870
New +$740K 0.01% 576
2023
Q2 		– Sell
-19,209
Closed -$780K – 750
2023
Q1 		$780K Buy
19,209
+1,826
+11% +$75.6K 0.01% 482
2022
Q4 		$781K Hold
17,383
– – 0.01% 476
2022
Q3 		$832K Buy
17,383
+514
+3% +$28.2K 0.02% 456
2022
Q2 		$998K Buy
16,869
+5,703
+51% +$468K 0.02% 437
2022
Q1 		$1.3M Buy
+11,166
New +$1.3M 0.02% 429

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

B. Metzler seel. Sohn & Co's TNDM Position: Q1 2025 in Review

B. Metzler seel. Sohn & Co sold out of Tandem Diabetes Care (TNDM) in Q1 2025, closing a stake of 21,870 shares — an estimated $788K sold.

B. Metzler seel. Sohn & Co first reported a position in TNDM in Q1 2022 and held it in 6 quarters. The position peaked at $1.3M in Q1 2022. 275 funds tracked by Wall St. Rank hold TNDM as of Q1 2025.

  • B. Metzler seel. Sohn & Co reported no remaining Tandem Diabetes Care position as of Q1 2025 after selling out during the quarter.
  • B. Metzler seel. Sohn & Co sold 21,870 Tandem Diabetes Care shares in Q1 2025, an estimated $788K.
  • B. Metzler seel. Sohn & Co first reported a position in Tandem Diabetes Care in Q1 2022 and held it in 6 quarters.
  • B. Metzler seel. Sohn & Co's Tandem Diabetes Care position peaked at $1.3M in Q1 2022.
  • 275 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2025.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q1 2025, filed 14 May 2025.